Analysts await Team Health Holdings, Inc. (NASDAQ:TMH) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $0.58 EPS, down 17.24% or $0.1 from last year’s $0.68 per share.

At the moment 17 analysts are watching Team Health Holdings, Inc. (NASDAQ:TMH), 7 rate it “Buy”, 4 “Outperform”, 6 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Jun-16, 16 analysts have a mean sales target of 1,160.98 million. For the quarter ending Sep-16, 16 analysts have a mean sales target of 1,196.15 million whilst for the year ending Dec-16, 17 analysts have a mean target of 4,730.20 million.

In terms of earnings per share, 17 analysts have a 0.68 EPS mean target for the quarter ending Jun-16, for the quarter ending Sep-16, 17 analysts have a 0.77 EPS mean target and for the quarter ending Sep-16 there are 17 estimates of 2.82 EPS.

The biggest institutional shareholders in Team Health Holdings, Inc. include Fidelity Management and Research Company which owns 9 million shares in the company valued at $396.46 million. Wellington Management Company LLP is the second biggest holder with 6 million shares currently valued at 280.98 million whilst Jana Partners LLC has 6 million shares valued at 262.53 million.

Total shares held by institutions as of the most recent company filings are 82,877,944 with a reported 14,391,638 bought and 6,578,406 sold. These holdings make up 98.71% of the company’s outstanding shares.

Currently insiders hold 432,195 shares in the business which makes up 0.59% of shares. The biggest holder currently is Sherlin Stephen who owns 142,103 shares (0.19% of those outstanding), whilst Mr. Greg Roth holds 96,664 (0.13% of shares outstanding) and Michael D. Snow holds 83,317 (0.11% of shares outstanding).

The stock increased 2.85% or $1.2 during the last trading session, hitting $43.28. Team Health Holdings, Inc. (NASDAQ:TMH) has fallen 35.95% over the past 6 months and is downtrending.